ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Kestra Medical Technologies, Ltd. Appoints Neil Bhalodkar as Vice President of Investor Relations

KIRKLAND, Wash., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, announced today that Neil Bhalodkar is joining the company as Vice President of Investor Relations, effective Monday, March 3, 2025.

“On behalf of all of Kestra and its stakeholders, I am delighted to welcome Neil to the team,” said Brian Webster, President and Chief Executive Officer at Kestra. “Neil is a seasoned investor relations leader with extensive experience in the medical technology sector. His deep understanding of the MedTech ecosystem will be an asset to Kestra as we work to grow and evolve the wearable defibrillator market.”

Mr. Bhalodkar joins Kestra with more than two decades of experience in investor relations, corporate finance, and equity research. Most recently, he led the investor relations function at Inari Medical until its acquisition by Stryker. Prior to this, he created and executed the investor relations program at Axonics from the time of the company’s commercial launch until its acquisition by Boston Scientific. Before moving to industry, Mr. Bhalodkar advised healthcare clients on corporate finance transactions and analyzed publicly traded healthcare companies.

“I am excited to collaborate with the Kestra leadership team and share the company’s compelling story with the investment community,” said Mr. Bhalodkar. “I look forward to contributing to Kestra’s mission of providing innovative, intuitive medical technologies to protect and support at-risk patients.”

About Kestra
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using diagnostic monitoring and therapeutic technologies that are intuitive, intelligent, and connected. Kestra was founded in 2014 by leaders from the external (AED) and implantable (ICD) defibrillation industries. For more information, visit www.kestramedical.com.

INVESTOR CONTACT
Marissa Bych or Webb Campbell
Gilmartin Group
investor.relations@kestramedical.com

MEDIA CONTACT
Rhiannon Pickus
Kestra Medical Technologies, Ltd.
Rhiannon.Pickus@kestramedical.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.42
+0.00 (0.00%)
AAPL  286.19
+0.00 (0.00%)
AMD  215.24
+0.00 (0.00%)
BAC  53.19
+0.00 (0.00%)
GOOG  316.02
+0.00 (0.00%)
META  647.10
+0.00 (0.00%)
MSFT  490.00
+0.00 (0.00%)
NVDA  181.46
+0.00 (0.00%)
ORCL  201.10
+0.00 (0.00%)
TSLA  429.24
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.